Cita APA (7a ed.)

LD, M., P, T., & AC, L. (2019). CPX-351: A nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties. Dove Medical Press.

Cita Chicago Style (17a ed.)

LD, Mayer, Tardi P, y Louie AC. CPX-351: A Nanoscale Liposomal Co-formulation of Daunorubicin and Cytarabine with Unique Biodistribution and Tumor Cell Uptake Properties. Dove Medical Press, 2019.

Cita MLA (8a ed.)

LD, Mayer, et al. CPX-351: A Nanoscale Liposomal Co-formulation of Daunorubicin and Cytarabine with Unique Biodistribution and Tumor Cell Uptake Properties. Dove Medical Press, 2019.